Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism
article
OA: closed
CC0
⤵ 11 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- Estradiol Valerate/Dienogest via openalex
- Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest via openalex
- Hormonal contraception: present and future via openalex
- The pharmacological profile of dienogest via openalex
- doi:10.1210/jc.2002-021528 via openalex
- W52369245 via openalex
- doi:10.1210/jcem.74.1.1530790 via openalex
- doi:10.1016/s0015-0282(03)01188-9 via openalex
- doi:10.1016/j.jacc.2008.09.042 via openalex
- doi:10.2337/diacare.27.6.1487 via openalex
- doi:10.1016/0002-9378(93)90432-i via openalex
- doi:10.1002/14651858.cd006133.pub3 via openalex
- doi:10.1093/humrep/del407 via openalex
- W6602104426 via openalex
- W6639397092 via openalex
- W6658274872 via openalex
- doi:10.1016/j.contraception.2005.09.014 via openalex
- doi:10.1093/humupd/5.6.721 via openalex
- doi:10.1210/er.2002-0015 via openalex
- doi:10.1016/j.fertnstert.2003.10.004 via openalex
- doi:10.1016/0026-0495(82)90143-3 via openalex
- doi:10.1016/j.contraception.2008.09.002 via openalex
- doi:10.1002/14651858.cd006133.pub5 via openalex
- doi:10.1016/j.maturitas.2005.01.004 via openalex
- doi:10.1016/0002-9378(78)90480-5 via openalex
- doi:10.1016/j.contraception.2007.05.080 via openalex
- doi:10.1007/s11154-011-9182-4 via openalex
- doi:10.1016/s0010-7824(98)00018-3 via openalex
Cited by (11)
- Estradiol Valerate vs Ethinylestradiol in Combined Oral Contraceptives: Effects on the Pituitary-Ovarian Axis 2022
- Needs, expectations and doubt users of hormonal contraceptives 2020
- Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome 2020
- Ethinyl estradiol vs estradiol valerate in combined oral contraceptives – Effect on glucose tolerance: A randomized, controlled clinical trial 2020
- Overview of the therapeutic possibilities of combined oral contraceptive containing estradiol valerate and dienogest 2019
- Estradiol valerate and dienogest in hormonal contraception. Acceptability and effectiveness in real clinical practice 2018
- Causes of Visiting Teenagers in the Pediatric and Adolescence Examining Room 2018
- ADMINISTRATION OF A COMBINED ORAL CONTRACEPTIVE CONTAINING ESTRADIOL VALERATE/DIENOGEST (E2V/DNG) BY WOMEN WITH MENORRHAGIA 2017
- Metabolic impact of combined hormonal contraceptives containing estradiol 2016
- Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature 2014
- 10.1016/j.yend.2013.10.001 2000
Source provenance
- openalex
- last seen: 2026-05-11T06:17:40.080092+00:00
License: CC0
· commercial use OK